Natural Products with Toll-Like Receptor 4 Antagonist Activity

被引:56
|
作者
Molteni, Monica [1 ]
Bosi, Annalisa [1 ]
Rossetti, Carlo [1 ]
机构
[1] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via Dunant 3, I-21100 Varese, Italy
关键词
D O I
10.1155/2018/2859135
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-Like Receptors (TLRs) are the innate immunity receptors that play an activating role when interacting with molecules released by bacteria and viruses (PAMPs, pathogen-associated molecular patterns) or with molecules released by injured cells and tissues (DAMPs, danger-associated molecular patterns). TLR triggering leads to the induction of proinflammatory cytokines and chemokines, driving the activation of both innate and adaptive immunity. In particular, Toll-Like Receptor 4 (TLR4) has been described to be involved in the inflammatory processes observed in several pathologies (such as ischemia/reperfusion injury, neuropathic pain, neurodegenerative diseases, and cancer). Molecules obtained by natural sources have been discovered to exert an anti-inflammatory action by targeting TLR4 activation pathways. This review focuses on TLR4 antagonists obtained from bacteria, cyanobacteria, and plants.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Polymorphisms in vitamin D receptor, toll-like receptor 2 and Toll-Like receptor 4 genes links with Dengue susceptibility
    Singh, Arvind Kumar
    Prakash, Shantanu
    Garg, R. K.
    Jain, Parul
    Kumar, Rashmi
    Jain, Amita
    BIOINFORMATION, 2021, 17 (04) : 506 - 513
  • [42] Role of genetic variants of Vitamin D receptor, Toll-like receptor 2 and Toll-like receptor 4 in extrapulmonary tuberculosis
    Wani, Bilal Ahmad
    Shehjar, Faheem
    Shah, Sonaullah
    Koul, Ajaz
    Yusuf, Adfar
    Farooq, Muzamil
    Mir, Mohmad Iqbal
    Singh, Rajni
    Afroze, Dil
    MICROBIAL PATHOGENESIS, 2021, 156
  • [43] CyP, a toll-like receptor 4 antagonist, protects the heart from ischemia/reperfusion injury
    Soldo, A.
    Molteni, M.
    Rossetti, C.
    Maggioni, S.
    Biondi, A.
    Gemma, S.
    Latini, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 690 - 690
  • [44] Toll-Like Receptor 4 Antagonist Attenuates Intracerebral Hemorrhage-Induced Brain Injury
    Wang, Yan-Chun
    Wang, Peng-Fei
    Fang, Huang
    Chen, Jing
    Xiong, Xiao-Yi
    Yang, Qing-Wu
    STROKE, 2013, 44 (09) : 2545 - 2552
  • [45] The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge
    Younan, Patrick
    Ramanathan, Palaniappan
    Graber, Jessica
    Gusovsky, Fabian
    Bukreyev, Alexander
    MBIO, 2017, 8 (02):
  • [46] Controlling the cytokine storm in severe bacterial diarrhoea with an oral Toll-like receptor 4 antagonist
    Islam, Dilara
    Lombardini, Eric
    Ruamsap, Nattaya
    Imerbsin, Rawiwan
    Khantapura, Patchariya
    Teo, Ian
    Neesanant, Pimmnapar
    Gonwong, Siriphan
    Yongvanitchit, Kosol
    Swierczewski, Brett E.
    Mason, Carl J.
    Shaunak, Sunil
    IMMUNOLOGY, 2016, 147 (02) : 178 - 189
  • [47] EFFECTS OF ERITORAN TETRASODIUM, A TOLL-LIKE RECEPTOR 4 ANTAGONIST, ON INTESTINAL MICROCIRCULATION IN ENDOTOXEMIC RATS
    Yeh, Yu-Chang
    Ko, Wen-Je
    Chan, Kuang-Cheng
    Fan, Shou-Zen
    Tsai, Jui-Chang
    Cheng, Ya-Jung
    Sun, Wei-Zen
    SHOCK, 2012, 37 (05): : 556 - 561
  • [48] CyP, a toll-like receptor 4 antagonist, protects the heart from ischemia/reperfusion injury
    Soldo, A.
    Molteni, M.
    Rossetti, C.
    Maggioni, S.
    Biondi, A.
    Gemma, S.
    Latini, R.
    EUROPEAN HEART JOURNAL, 2011, 32 : 690 - 690
  • [49] Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA
    Shibata, Akitaka
    Sugiura, Kazumitsu
    Furuta, Yasuhide
    Mukumoto, Yoshiko
    Kaminuma, Osamu
    Akiyama, Masashi
    JOURNAL OF AUTOIMMUNITY, 2017, 80 : 28 - 38
  • [50] Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update
    Peri, Francesco
    Calabrese, Valentina
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (09) : 3612 - 3622